analytical
procedures described in this method:
Antoinette C. Ruschman-Cardinal Laboratories, Inc., 622 Buttermilk Pike, Covington, Kentucky 41017
Disclaimer
This method has been submitted to the U.S
M 1 2 3 N
bp
–930
–810
–622
Figure 3. CD-PCR for Enterococci, Actinomycetes,
Serratia, and Legionella
Lane Sample
M Marker (100-bp ladder)
N Negative control (without
added bacteria)
1 S.
IP human, rat �75923 1 Set €206
Anti-Muscarinic M2 Acetylcholine Receptor (225-356) Rabbit
pAb
FFS, FS, IB, IP; NOT PS human, mouse, rat �7592� 1 Set €206
Anti-c-Myc (Ab-1) Mouse mAb (9E10) FC
IP human, rat 47592� 1 Set €179
Anti-Muscarinic M2 Acetylcholine Receptor (225-�56) Rabbit
pAb
FFS, FS, IB, IP; NOT PS human, mouse, rat 475924 1 Set €179
Anti-c-Myc (Ab-1) Mouse mAb (9E10) FC
20) may be substituted.
If additional Assay Diluent is needed, 10 mM Tris pH 7.5, 225 mM NaCl, 0.05%
Tween-20, 1% BSA may be substituted.
If additional 96-well filter plates are required, we recommend
P7114 M y n/d n/d
620 phospho-Pyk2 (pTyr579/580) P6989 P y n/d n/d
621 AP2 alpha P6739 M y n/d n/d
622 Negative Control NA
623 Rab5 R7904 M y y y
624 Anti Cy3+Cy5 C0992 M NA NA NA
625 Rab 7 R8779 M y
22015925 591
RD15LD 15 kg 0,5 g 350 x 240 mm 22017357 622
RD15LD AP 6/15 kg 2/5 g 350 x 240 mm 22015937 670
RD35LD 35 kg 1 g 350 x 240 mm 22017376 622
RD35LD AP 15/35 kg 5/10 g 350 x